Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1234 | Clinical Cases–Pituitary/Adrenal | ECE2015

Hemangiopericytoma associated hypoglycaemia and concomitant secondary adrenal insufficiency

Kiyici Sinem , Topyildiz Figen , Polat Bunyamin , Hunuk Ahmet

Introduction: Hemangiopericytomas (HPC) are rare vascular tumours that may be associated with hypoglycaemia. Here we report a case of HPC with multiple metastases, accompanying severe recurrent hypoglycaemia due to the combination of different aetiologies.Case report: A 21 year-old woman was hospitalised due to loss of consciousness. The patient has been diagnosed as HPC by tibia mass biopsy 1 year ago. Tumour embolization was made several times. On admi...

ea0035p459 | Diabetes complications | ECE2014

Prevalence of gastrointestinal diseases in the newly diagnosed pre-diabetic and diabetic patients

Cander Soner , Gul Ozen Oz , Topyildiz Figen , Ersoy Canan

Aim: Delayed gastric emptying affects a substantial proportion of patients with long-standing diabetes. On the other hand changes in gastric incretin hormones also play an important role in the pathophysiology of diabetes. In our study, we aimed to investigate the incidence of gastrointestinal disease in patients with newly diagnosed diabetes and pre-diabetes.Methods: A total of 73 patients with newly diagnosed pre-diabetes and diabetes were included in ...

ea0035p484 | Diabetes therapy | ECE2014

Normal and extended release form of metformin in type 2 diabetıc and pre-diabetic patients.

Cander Soner , Gul Ozen Oz , Topyildiz Figen , Ersoy Canan

Aim: Metformin is usually well-tolerated and commonly used oral-antidiabetic in type-2 diabetes and pre-diabetes. The most common side effects are gastrointestinal (GI) ones. It is proposed that, extended-release form of metformin has less gastrointestinal side effects. We aimed to compare the extended-release and normal-release form metformin in type-2 diabetic and prediabetic patients for gastrointestinal tolerability, weight effect and glycemic control.<p class="abstext...

ea0037ep452 | Diabetes (complications &amp; therapy) | ECE2015

The effect of exenatide treatment on serum ghrelin levels in patients with type 2 diabetes

Topyildiz Figen , Kiyici Sinem , Gul Zulfiye , Sigirli Deniz , Guclu Metin , Kisakol Gurcan , Cavun Sinan

Aim: Ghrelin plays an important role in stimulation of food intake and long-term regulation of body weight. In present study we aimed to investigate the effect of exenatide treatment on serum ghrelin levels in patients with type 2 diabetes.Methods: Fourteen women patients with type 2 diabetes treated with metformin and exenatide were enrolled in the study. A mixed meal test was applied to the patients while they were using their daily medications. Serum ...